Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 139, Issue 3, Pages S1-S46Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2016.09.023
Keywords
Immune globulin; immunoglobulin; IVIG; SCIG; IGIV; transfusion; adverse events; primary immunodeficiency; immunomodulation; immune modulating; autoimmunity
Categories
Ask authors/readers for more resources
Human immunoglobulin preparations for intravenous or subcutaneous administration are the cornerstone of treatment in patients with primary immunodeficiency diseases affecting the humoral immune system. Intravenous preparations have a number of important uses in the treatment of other diseases in humans as well, some for which acceptable treatment alternatives do not exist. We provide an update of the evidence-based guideline on immunoglobulin therapy, last published in 2006. Given the potential risks and inherent scarcity of human immunoglobulin, careful consideration of its indications and administration is warranted. (J Allergy Clin Immunol 2017; 139: S1-46.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available